Thailand signs deal with Pfizer to supply 2 million anti-viral Paxlovid tablets

14 Sept 01:29 Key points summarised by AI

Thailand's Medical Services Department finalized a deal with Pfizer to procure 2 million Paxlovid anti-viral tablets for COVID-19 treatment.
Paxlovid is an oral medication proven to reduce the risk of hospitalization and death in severe COVID-19 cases by approximately 88% when administered within five days of symptom onset.
The drug is specifically recommended for infected individuals with mild symptoms who are at high risk of developing severe illness, such as the elderly or those with chronic conditions.
This procurement supplements Thailand's existing anti-viral arsenal, which recently included 2 million tablets of Molnupiravir from Merck.

Thailand News in Brief